首页> 外文会议>SPIE Conference on Computer-Aided Diagnosis >Computer-Aided Detection of Hepatocellular Carcinoma in Multiphase Contrast-Enhanced Hepatic CT: A Preliminary Study
【24h】

Computer-Aided Detection of Hepatocellular Carcinoma in Multiphase Contrast-Enhanced Hepatic CT: A Preliminary Study

机译:多相对比度增强肝CT中肝细胞癌的计算机辅助检测:初步研究

获取原文

摘要

Malignant liver tumors such as hepatocellular carcinoma (HCC) account for 1.25 million deaths each year worldwide. Early detection of HCC is sometimes difficult on CT images because the attenuation of HCC is often similar to that of normal liver parenchyma. Our purpose was to develop computer-aided detection (CADe) of HCC using both arterial phase (AP) and portal-venous phase (PVP) of contrast-enhanced CT images. Our scheme consisted of liver segmentation, tumor candidate detection, feature extraction and selection, and classification of the candidates as HCC or non-lesions. We used a 3D geodesic-active-contour model coupled with a level-set algorithm to segment the liver. Both hyper- and hypo-dense tumors were enhanced by a sigmoid filter. A gradient-magnitude filter followed by a watershed algorithm was applied to the tumor-enhanced images for segmenting closed-contour regions as HCC candidates. Seventy-five morphologic and texture features were extracted from the segmented candidate regions in both AP and PVP images. To select most discriminant features for classification, we developed a sequential forward floating feature selection method directly coupled with a support vector machine (SVM) classifier. The initial CADe before the classification achieved a 100% (23/23) sensitivity with 33.7 (775/23) false positives (FPs) per patient. The SVM with four selected features removed 96.5% (748/775) of the FPs without any removal of the HCCs in a leave-one-lesion-out cross-validation test; thus, a 100% sensitivity with 1.2 FPs per patient was achieved, whereas CADe using AP alone produced 6.4 (147/23) FPs per patient at the same sensitivity level.
机译:恶性肝脏肿瘤如肝细胞癌(HCC)占全球每年125万人死亡。 HCC的早期检测有时难以在CT图像上困难,因为HCC的衰减通常与正常肝脏实质的衰减相似。我们目的是使用对比度增强的CT图像的动脉阶段(AP)和门静脉相(PVP)来开发HCC的计算机辅助检测(CADE)。我们的方案由肝脏分割,肿瘤候选检测,特征提取和选择,以及作为HCC或非病变的候选者的分类。我们使用了一个与级别集合算法耦合的3D测地值 - 辅助模型,以分割肝脏。 Sigmoid过滤器增强了超致密的肿瘤均得到增强。梯度幅度滤波器,然后应用于肿瘤增强的图像,用于将闭合轮廓区域分割为HCC候选。从AP和PVP图像中的分段候选区域提取七十五的形态学和纹理特征。要选择分类的大多数判别特征,我们开发了一个顺序前进浮动特征选择方法,直接与支持向量机(SVM)分类器耦合。分类之前的初始CADE实现了100%(23/23)敏感性,每位患者的33.7(775/23)误报(FPS)。具有四个选定特征的SVM除以FPS的96.5%(748/775),无需在休假效率交叉验证测试中移除HCC;因此,实现了每位患者1.2fps的100%敏感性,而在同一敏感性水平下,每单独使用AP的AP(147/23)FPS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号